level-one heading

Why Kolabtree
Getting started is quick and easy. No upfront fees
It’s free to request a service and invite bids from experts
Discuss requirements with the expert in detail before accepting statement of work from Kolabtree
Collaborate with the expert directly to get your work done the right way
Fund project when you hire the expert, but approve the deliverables only once work is done
Want to hire this expert for a project? Request a quote for free.
Profile Details
Create Project
★★★★★
☆☆☆☆☆
Hire Kinga K.
Poland

Clinical data analyst and medical writer with 4 years experience in clinical research and systematic review.

Profile Summary
Subject Matter Expertise
Services
Writing Clinical Trial Documentation, Medical Writing, Technical Writing, General Proofreading & Editing, Translation
Work Experience

Clinical Data Analyst

HEALTH QUEST SP. Z O.O.

September 2023 - Present

Clinical Data Analyst

CENTRUM HTA SP. Z O.O.

March 2022 - September 2023

Research Worker

Jagiellonian University Cracow

October 2018 - June 2022

Education

Master's in Biological sciences

Jagiellonian University Cracow - Poland

October 2019 - July 2021

Bachelor’s in Biological sciences

Jagiellonian University Cracow - Poland

October 2016 - July 2019

Certifications
  • MS Excel - intermediate level

    Imperium Szkoleniowe

    June 2025 - Present

  • SQL language - basic level

    Imperium Szkoleniowe

    June 2025 - Present

  • GCP - Good Clinical Practise

    Medical Research Agency

    January 2025 - Present

  • Documentation in clinical trials

    Szkolenia biomedyczne

    January 2025 - Present

  • Biostatistics in clinical trials

    Szkolenia biomedyczne

    January 2024 - Present

  • Monitoring clinical trials - basic and advanced part

    Soft Communication

    October 2022 - Present

Publications
JOURNAL ARTICLE
Kinga Krawczyk, Katarzyna Śladowska, Przemysław Holko, Paweł Kawalec (2023). Comparative safety of tyrosine kinase inhibitors in the treatment of metastatic renal cell carcinoma: a systematic review and network meta-analysis . Frontiers in Pharmacology.
Justyna Gogola, Weronika Marynowicz, Kinga Krawczyk, Anna Ptak (2023). Visfatin increases the invasive potential of ovarian granulosa tumor spheroids by reprogramming glucose metabolism . Reproduction.
Justyna Gogola-Mruk, Kinga Krawczyk, Weronika Marynowicz, Magdalena Rokita, Samantha Nimpsz, Anna Ptak (2023). Bisphenols S and F drive ovarian granulosa cell tumor invasion via a metabolic switch . Toxicology Letters.
Justyna Gogola, Wacław Tworzydło, Kinga Krawczyk, Weronika Marynowicz, Anna Ptak (2023). Visfatin induces ovarian cancer resistance to anoikis by regulating mitochondrial activity . Endocrine.
Kinga Krawczyk, Weronika Marynowicz, Karolina Pich, Oliwia Jędruch, Gabriela Kania, Justyna Gogola-Mruk, Wacław Tworzydło, Zbigniew Polański, Anna Ptak (2022). Persistent organic pollutants affect steroidogenic and apoptotic activities in granulosa cells and reactive oxygen species concentrations in oocytes in the mouse . Reproduction, Fertility and Development.
Kinga Krawczyk, Weronika Marynowicz, Justyna Gogola-Mruk, Klaudia Jakubowska, Waclaw Tworzydlo, Małgorzata Opydo, Anna Ptak (2021). A mixture of persistent organic pollutants detected in human follicular fluid increases progesterone secretion and mitochondrial activity in human granulosa HGrC1 cells . Reproductive Toxicology.